RBGPF - Reckitt Benckiser: Poor Sales Volumes Are Reflected In Valuation
2024-06-03 22:31:35 ET
Summary
- Reckitt Benckiser manufactures and sells a diverse range of health, hygiene, and home products.
- Underneath historical revenue growth, organic sales volumes are performing poorly, as acquisitions and inflation have driven growth in recent years.
- The current financial performance has started to reflect the poorer underlying volume growth.
- The valuation has started to price in poor future growth, and some short-term upside now exists.
Based in the United Kingdom, Reckitt Benckiser Group ( OTCPK:RBGPF , OTCPK:RBGLY ) manufactures and sells health, hygiene, and home products with products such as facial care products, first aid products, footcare products, women’s beauty products, and cleaning products such as toilet bowl cleaners and pest control products – the company has a very diverse portfolio of products. Reckitt Benckiser’s most well-recognized brands include Cillit Bang, Airborne, Durex, Strepsils, and Lysol. Reckitt Benckiser’s revenues have nearly equal contributions from North America, Europe/ANZ, and developing markets....
Reckitt Benckiser: Poor Sales Volumes Are Reflected In Valuation